LEW-97040-77349
1 vaccination
2 coded responses
6 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 554 / MN
- Registered
- 2021-04-08
- Relationship
- Self
- Race
- Asian
- Ethnicity
- N/A
Timeline
-
2021-04-08
Registered in v-safe
-
2021-04-08
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-08
Health check-in — day 0, dose 1Feeling: Good · Site: Pain, Redness · Fever · Headache, Fatigue or tirednessAdult check-in
-
2021-04-09
Survey response — days 1–6 daily, dose 1MedDRA: Rhinorrhoea, Sneezing — Feeling: Fair · Site: Itching · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workFree text: Running nose and sneezingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-09
- 2021-04-10
-
2021-04-11
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness — Feeling: Fair · NauseaFree text: DizzyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-13
- 2021-04-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-08 | Janssen/Johnson & Johnson |
Call center
1 check-in flagged for a call with no call center case on record
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Running nose and sneezing
Systemic reaction (other): Dizzy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Sneezing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release